Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5969229 | 0.80 | — | — | |
| SCHEMBL7106181 | 0.78 | ANPEP (0.38) | DNM1ALDH1A1TDP1MAPTLMNA | |
| SCHEMBL19329908 | 0.78 | — | — | |
| SCHEMBL7772676 | 0.73 | — | — | |
| SCHEMBL10231127 | 0.73 | — | — | |
| SCHEMBL14571190 | 0.71 | DNM1 (0.45) | DNM1ALDH1A1TDP1MAPTTSHR | |
| SCHEMBL509074 | 0.71 | — | — | |
| SCHEMBL710445 | 0.70 | DNM1 (0.35) | DNM1ALDH1A1TDP1MAPTTSHR | |
| SCHEMBL3407796 | 0.69 | — | — | |
| SCHEMBL16233629 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023003038-A1 | ORGANIC ELECTRONICS MATERIAL AND ORGANIC ELECTRONICS ELEMENT | 昭和電工マテリアルズ株式会社 | 2023-01-26 | — | — | WO | claimed |
| EP-1763542-B1 | TECHNIQUE FOR SELECTING POLYMERIZATION MODIFIERS | DOW GLOBAL TECHNOLOGIES INC (US) | 2011-04-06 | — | — | EP | claimed |
| US-7553917-B2 | Technique for selecting polymerization modifiers cross reference statement | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2009-06-30 | — | — | US | claimed |
| US-20070219327-A1 | Technique for Selecting Polymerization Modifiers Cross Reference Statement | DOW GLOBAL TECHNOLOGIES INC. | 2007-09-20 | — | — | US | claimed |
| EP-1763542-A2 | TECHNIQUE FOR SELECTING POLYMERIZATION MODIFIERS CROSS REFERENCE STATEMENT | Dow Gloval Technologies Inc. (US) | 2007-03-21 | — | — | EP | claimed |
| WO-2006007094-A2 | TECHNIQUE FOR SELECTING POLYMERIZATION MODIFIERS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-01-19 | — | — | WO | claimed |
| US-6919291-B2 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-07-19 | — | — | US | claimed |
| US-6812360-B2 | TREATING DIABETES MELLITUS BY ADMINISTERING A FRUCTOSAMINE OXIDASE INHIBITOR SUCH AS A HYDRAZINE COMPOUND, N-ALPHA-CBZ-L-ARGININE OR ACETYLPENICILLAMINE. | NIPPON SHOKUBAI CO., LTD. (JP) | 2004-11-02 | — | — | US | claimed |
| US-20040110631-A1 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-06-10 | — | — | US | claimed |
| EP-1246854-B1 | PREPARATION OF POLYMERIZATION CATALYST AND RELATED POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC (US) | 2004-05-26 | — | — | EP | claimed |
| EP-1153026-A1 | PROCESS FOR PREPARING TRIFLUOROARYLALUMINUM ETHERATES | THE DOW CHEMICAL COMPANY (US) | 2001-11-14 | — | — | EP | claimed |
| US-6248265-B1 | Clean generation of a fluoroaryl grignard reagent | ALBEMARLE CORPORATION | 2001-06-19 | — | — | US | claimed |
| WO-2001038409-A1 | PREPARATION OF POLYMERISATION CATALYST COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2001-05-31 | — | — | WO | claimed |
| US-6235222-B1 | REACTING, IN SOLVENT CONTAINING CHAIN ETHER SOLVENT, HYDROCARBON MAGNESIUM HALIDE WITH FLUOROARYL HALIDE | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-05-22 | — | — | US | claimed |
| EP-1093476-A1 | IMPROVED SYNDIOTACTIC MONOVINYLIDENE AROMATIC POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 2001-04-25 | — | — | EP | claimed |
| US-6160146-A | Process for preparing trifluoroarylaluminum etherates | THE DOW CHEMICAL COMPANY (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000049023-A1 | PROCESS FOR PREPARING TRIFLUOROARYLALUMINUM ETHERATES | THE DOW CHEMICAL COMPANY (US) | 2000-08-24 | — | — | WO | claimed |
| EP-0995753-A2 | Method for manufacturing fluoroaryl magnesium halide | Nippon Shokubai Co., Ltd. (JP) | 2000-04-26 | — | — | EP | claimed |
| WO-2000000523-A1 | IMPROVED SYNDIOTACTIC MONOVINYLIDENE AROMATIC POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 2000-01-06 | — | — | WO | claimed |
| EP-0838466-A2 | Producing process of (fluoroaryl) borane compound and producing process of tetrakis (fluoroaryl) borate derivative | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-04-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110631-A1 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | FZD7, FOS, COG4 | DNM1 476/4885ALDH1A1 3691/4885TDP1 2892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.